Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_DB00051
http://purl.obolibrary.org/obo/dinto_DB00051
|
|---|---|
| Preferred Name | adalimumab |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | adalimumab
|
|---|---|
| label | adalimumab
|
| DBSynonym | ig gamma-1 chain c region
|
| ATCCode | L04AB04
|
| Definition | Adalimumab is a human monoclonal antibody against TNF-alpha. It is produced by recombinant DNA technology using a mammalian cell expression system. It consists of 1330 amino acids and has a molecular weight of approximately 148 kilodaltons.
|
| has pharmacological target | |
| type | |
| AHFScode | 92:00.00
|
| xref |
GenBank:J00228
Wikipedia:http://en.wikipedia.org/wiki/Adalimumab
National Drug Code Directory:0074-3799-02
UniProtKB:P01857
RxList:http://www.rxlist.com/cgi/generic3/humira.htm
Drugs.com:http://www.drugs.com/cdi/adalimumab.html
PharmGKB:PA10004
Drugs Product Database (DPD):2258595
See more
See less
|
| CASRN | 331731-18-1
|
| prefixIRI | obo2:dinto_DB00051
|
| related with |
See more
See less
|
| may interact with | |
| DBBrand |
humira (abbott laboratories)
humira
humira pen
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |